Align Technology beats fourth-quarter results estimates on dental products demand

Reuters
02/05
Align Technology beats fourth-quarter results estimates on dental products demand

By Unnamalai L

Feb 4 (Reuters) - Align Technology ALGN.O reported quarterly results above Wall Street expectations and forecast first-quarter revenue in line with estimates, driven by strong demand for its dental aligners.

Shares of the company were up more than 10% in after-hours trading.

Demand for dental products has been sluggish in the past few quarters due to uneven dental visits. Analysts expect 2026 to see more stable demand, although they remain cautious about a full recovery in the broader market.

Align, which makes teeth retainers, dental scanners and software for dental laboratories and practitioners, expects its first-quarter global revenue to be between $1.01 billion and $1.03 billion, compared with analysts' estimates of $1.02 billion, according to data compiled by LSEG.

"Align finished off 2025 on a high note," said Evercore ISI Elizabeth Anderson, noting that the initial 2026 revenue outlook appears both encouraging and prudent.

First-quarter revenue outlook is broadly in line with analysts' expectations, though stronger pricing and mid‑single‑digit case growth could lift results, Anderson added.

The company expects volume growth for its flagship product, Clear Aligner, to be up mid-single digits on a year-over-year basis in 2026, compared to growth of 4.7% in 2025.

It expects annual revenue growth to be up 3% to 4% year-over-year.

On an adjusted basis, the company earned a profit of $3.29 per share for the quarter ended December 31, beating analysts' estimates of $2.97 per share. Revenues of $1.05 billion were above estimates of $1.03 billion.

(Reporting by Unnamalai L in Bengaluru; Editing by Vijay Kishore)

((Unnamalai.L@thomsonreuters.com;))

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10